The ACCC has won its request for an injunction blocking rail freight operator Aurizon from shutting its intermodal business down while a competition lawsuit the regulator filed over Aurizon’s proposed sale of the business to Pacific National makes its way through the court.
Pharmaceutical and life sciences giant Bayer is facing a potential class action in Australia over its birth control device Essure, which can allegedly cause nickel poisoning and other severe complications.
McDonald’s has agreed to change its Corner Cafe logo, after the famed Corner Hotel in Melbourne filed a lawsuit claiming the global food giant’s new hipster cafe violates its trade marks.
Murray Goulburn’s ex-CFO Bradley Hingle has quietly settled a case brought by the consumer watchdog over the dairy co-operative’s allegedly misleading promises about farmgate milk prices, with the former executive agreeing to stay away from the dairy industry for three years.
Two group members of a resolved class action over managed investment schemes operated by agribusiness Great Southern Group are bound by the settlement deed to repay loans they took out with the Bendigo and Adelaide Bank, despite the severe constraints the settlement placed on individual defences, a judge has ruled.
Consumer goods giant Reckitt Benckiser has been ordered by the Federal Court to remove all in-store advertising for its Strepfen throat lozenges after a successful interlocutory application by rival iNova Pharmaceuticals.
The Federal Court offers group members in the shareholder class actions against AMP a major legal advantage over the NSW Supreme Court, lawyers for the federal cases have argued ahead of a hearing in the controversial jurisdictional battle.
When it comes to bet-the-company matters that keep corporate counsel awake at night, intellectual property disputes often rank at the top of the list. And these eight law firms are the ones companies turned to the most last year when facing a courtroom battle over their IP.
Slater and Gordon has filed a shareholder class action against Brambles over its allegedly misleading and overly rosy 2017 financial forecasts, beating rival Maurice Blackburn to the punch almost 10 months after it announced it was investigating a shareholder class action against the logistics company.
Ophthalmic diagnostic device manufacture ObjectiVision can’t file amended claims for damages following a trial in a copyright and contract case against the University of Sydney, with a judge saying the school would be “severely prejudiced” if the new claims were allowed.